Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression

被引:117
作者
Goette, Andreas [1 ]
Bukowska, Alicja [2 ]
Lendeckel, Uwe [2 ]
Erxleben, Michaela [1 ]
Hammwoehner, Matthias [1 ]
Strugala, Denis [1 ]
Pfeiffenberger, Jan [1 ]
Roehl, Friedrich-Wilhelm [3 ]
Huth, Christof [4 ]
Ebert, Matthias P. A. [5 ]
Klein, Helmut U. [1 ]
Roecken, Christoph [6 ]
机构
[1] Otto von Univ Hosp Magdeburg, Div Cardiol, D-39120 Magdeburg, Germany
[2] Otto von Univ Hosp Magdeburg, Inst Expt Internal Med, D-39120 Magdeburg, Germany
[3] Otto von Univ Hosp Magdeburg, Inst Biometr, D-39120 Magdeburg, Germany
[4] Otto von Univ Hosp Magdeburg, Dept Cardiovasc Surg, D-39120 Magdeburg, Germany
[5] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany
[6] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany
关键词
arrhythmia; cell adhesion molecules; fibrillation; oxidative stress; endocardium; stroke;
D O I
10.1161/CIRCULATIONAHA.107.730101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Increased levels of inflammatory markers are predictors of thromboembolic events during atrial fibrillation (AF). Increased endocardial expression of adhesion molecules (ie, vascular cell adhesion molecule [VCAM] and intercellular adhesion molecule [ICAM] could be an important link between initiation of inflammatory and prothrombogenic mechanisms responsible for thrombus development at the atrial endocardium (endocardial remodeling). Methods and Results-Tissue microarrays were used to screen right atrial tissue specimens obtained from 320 consecutive patients for differences in atrial expression of the prothrombogenic proteins VCAM-1, ICAM-1, thrombomodulin, plasminogen activator inhibitor-1, and von Willebrand factor. An in vitro organotypic human atrial tissue model and a pig model of rapid atrial pacing were used to determine the therapeutic impact of angiotensin II receptor blockade. Immunohistochemical analyses showed that all prothrombogenic proteins are expressed by endocardial cells. Using multivariable analysis, only the intensity of VCAM-1 expression was increased in patients with AF (P = 0.03). Increased atrial VCAM-1 expression was confirmed by Western blotting in patients with persistent and paroxysmal AF (persistent AF 207 +/- 42% versus sinus rhythm 100 +/- 16%, P = 0.028; paroxysmal AF 193 +/- 42%, P = 0.024 versus sinus rhythm). In vitro pacing of ex vivo human atrial tissue slices confirmed that rapid activation causes VCAM-1 upregulation (mRNA and protein levels). Pacing-induced VCAM-1 expression was abolished by olmesartan. To confirm this finding in vivo, VCAM-1 expression was determined in 14 pigs after rapid atrial pacing (600 bpm). Atrial tachycardia caused an upregulation of VCAM-1 expression, which was prevented by irbesartan, consistent with the observed increase in plasma levels of angiotensin II. Alterations in the in vivo VCAM-1 expression were more pronounced in the left atrium (> 5-fold compared with sham) than in the right atrium (3.5-fold compared with sham). Conclusions-AF and rapid atrial pacing both increase endocardial VCAM-1 expression, which can be attenuated by angiotensin II receptor blockade. This provides evidence that angiotensin II plays a pathophysiological role in prothrombotic endocardial remodeling.
引用
收藏
页码:732 / 742
页数:11
相关论文
共 36 条
[1]   Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat [J].
Ausma, J ;
Wijffels, M ;
Thone, F ;
Wouters, L ;
Allessie, M ;
Borgers, M .
CIRCULATION, 1997, 96 (09) :3157-3163
[2]   CHARACTERISTICS AND PROGNOSIS OF LONE ATRIAL-FIBRILLATION - 30-YEAR FOLLOW-UP IN THE FRAMINGHAM-STUDY [J].
BRAND, FN ;
ABBOTT, RD ;
KANNEL, WB ;
WOLF, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (24) :3449-3453
[3]   Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation [J].
Bukowska, A ;
Lendeckel, U ;
Hirte, D ;
Wolke, C ;
Striggow, F ;
Röhnert, P ;
Huth, C ;
Klein, HU ;
Goette, A .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (03) :333-342
[4]   Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation - Potential mechanisms for atrial thrombosis and stroke [J].
Cai, H ;
Li, ZM ;
Goette, A ;
Mera, F ;
Honeycutt, C ;
Feterik, K ;
Wilcox, JN ;
Dudley, SC ;
Harrison, DG ;
Langberg, JJ .
CIRCULATION, 2002, 106 (22) :2854-2858
[5]   Soluble vascular cell adhesion molecule 1 and N-terminal Pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease [J].
Campbell, DJ ;
Woodward, M ;
Chalmers, JP ;
Colman, SA ;
Jenkins, AJ ;
Kemp, BE ;
Neal, BC ;
Patel, A ;
MacMahon, SW .
ARCHIVES OF NEUROLOGY, 2006, 63 (01) :60-65
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159
[7]   C-reactive protein elevation in patients with atrial arrhythmias - Inflammatory mechanisms and persistence of atrial fibrillation [J].
Chung, MK ;
Martin, DO ;
Sprecher, D ;
Wazni, O ;
Kanderian, A ;
Carnes, CA ;
Bauer, JA ;
Tchou, PJ ;
Niebauer, MJ ;
Natale, A ;
Van Wagoner, DR .
CIRCULATION, 2001, 104 (24) :2886-2891
[8]   Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation [J].
Conway, DSG ;
Buggins, P ;
Hughes, E ;
Lip, GYH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (11) :2075-2082
[9]   Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation [J].
da Cunha, V ;
Tham, DM ;
Martin-McNulty, B ;
Deng, G ;
Ho, JJ ;
Wilson, DW ;
Rutledge, JC ;
Vergona, R ;
Sullivan, ME ;
Wang, YX .
ATHEROSCLEROSIS, 2005, 178 (01) :9-17
[10]   Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage - Role of the NADPH and xanthine oxidases [J].
Dudley, SC ;
Hoch, NE ;
McCann, LA ;
Honeycutt, C ;
Diamandopoulos, L ;
Fukai, T ;
Harrison, DG ;
Dikalov, SI ;
Langberg, J .
CIRCULATION, 2005, 112 (09) :1266-1273